Shopping Cart
Remove All
Your shopping cart is currently empty
Famitinib malate (SHR1020) is an orally active multi-targeted kinase inhibitor that effectively inhibits the activity of c-kit, VEGFR-2, and PDGFRβ with IC50 values of 2.3 nM, 4.7 nM, and 6.6 nM, respectively. It induces cell apoptosis and demonstrates potent antitumor activity in human gastric cancer cells and xenografts, making it a valuable compound for cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,970 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,580 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,400 | 8-10 weeks | 8-10 weeks |
| Description | Famitinib malate (SHR1020) is an orally active multi-targeted kinase inhibitor that effectively inhibits the activity of c-kit, VEGFR-2, and PDGFRβ with IC50 values of 2.3 nM, 4.7 nM, and 6.6 nM, respectively. It induces cell apoptosis and demonstrates potent antitumor activity in human gastric cancer cells and xenografts, making it a valuable compound for cancer research. |
| Targets&IC50 | VEGFR2:4.2 nM, PDGFRβ:6.6 nM, c-Kit:2.3 nM |
| Synonyms | SHR1020 malate |
| Molecular Weight | 544.57 |
| Formula | C27H33FN4O7 |
| Cas No. | 1256377-67-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.